XPH Enjoys Unusual Trading Patterns
The SPDR S&P Pharmaceuticals ETF (XPH) experienced a surge in trading activity on Thursday afternoon, with over 176,000 shares exchanged compared to its usual 27,000 shares over three months. XPH shares dipped by 0.8% during the day.
Top Performers and Laggards in XPH ETF
Notable components within the ETF included Pfizer, which saw a 2.1% decline with more than 16.0 million shares traded. Bristol-Myers Squibb also decreased by 0.2% with over 2.0 million shares changing hands. On a positive note, Harmony Biosciences Holdings soared by 3.7%, while Nuvation Bio struggled, dropping by 5.2%.
VIDEO: Thursday’s ETF with Unusual Volume: XPH
The views and opinions expressed here are of the author and do not reflect Nasdaq, Inc.’s views and opinions.
